Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Ogsiveo (nirogacestat) for Adults with Desmoid Tumors
SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced today...
Head Injury Left Her Memory-Impaired. A New Brain Implant Has Brought Memory Back
Gina Arata had a bright future, wrapping up college and preparing for law school, when a 2001 car wreck left her with lasting brain damage.After her recovery,...
Immediate Body Contact With Parents Helps Preemie Newborns Thrive
Having mom or dad hold their preemie baby against their own skin immediately after birth appears to help the infants in their development months later,...
Do You Overindulge During the Holidays? Poll Finds You're Not Alone
Holiday festivities bring joy to many, but they also give rise to quite a few unhealthy habits, a new survey has found. Two-thirds of people say they...
'High Altitude' Simulations Might Shield Patients Ahead of Surgery
Surgery coming up? Mimicking the high-altitude breathing of mountaineers might make your procedure safer, a tiny study suggests. It's a form of what surgeons...
Everest Medicines Announces Investigational New Drug Application Acceptance of Zetomipzomib in China
SHANGHAI, Dec. 3, 2023. Everest Medicines ("Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization...
Amid Salmonella Outbreak, Consumers Should Avoid Unknown Brands of Cantaloupe
As the Salmonella outbreak linked to cantaloupes continues to widen, the U.S. Centers for Disease Control and Prevention urges consumers to avoid any precut...
2011 to 2022 Saw Little Change in Smoking Prevalence for Older Adults
Between 2011 and 2022, there were significant decreases in smoking prevalence among younger adults, but not older adults, according to a study published...
Bidirectional Relationship Seen Between Overactive Bladder, Poor Sleep
There is a bidirectional relationship between overactive bladder (OAB) and poor sleep patterns, according to a study published online Nov. 13 in BMC...
Lipid-Lowering Drugs Save Lives, but Use Decreasing
Lipid-lowering drugs for primary prevention are associated with a significant survival benefit, but use has decreased over time, according to a study published...
Clarity's theranostic prostate cancer trial progresses at the highest dose level cohort
SYDNEY, Nov. 29, 2023. Clarity Pharmaceuticals ("Clarity"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products...
Monthly News Roundup - November 2023
FDA Approves Lilly’s Zepbound for Chronic Weight Management In November, the U.S. Food and Drug Administration (FDA) approved Eli Lilly’s...
Your Walking Speed Influences Your Risk for Diabetes
People can walk away their risk of developing type 2 diabetes – but only if they walk fast enough, a new report finds. Folks who walk at least 2.5...
FDA Warns of Rare But Serious Drug Reaction to the Antiseizure Medicines Levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and Clobazam (Onfi, Sympazan)
FDA Warns of Rare But Serious Drug Reaction to the Antiseizure Medicines Levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and Clobazam (Onfi, Sympazan) What...
FDA Investigating Serious Risk of T-cell Malignancy Following BCMA-Directed or CD19-Directed Autologous Chimeric Antigen Receptor (CAR) T cell Immunotherapies
The Food and Drug Administration (FDA) has received reports of T-cell malignancies, including chimeric antigen receptor CAR-positive lymphoma, in patients...
Recently Added
Recently added consumer and prescribing information: Ogsiveo, DefenCath, Adzynma, Zituvimet, Voquezna, Combogesic IV, Omvoh, Zymfentra, Cabtreo, Tofidence
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Ogsiveo Ogsiveo (nirogacestat) is an gamma secretase inhibitor in development for the treatment of adults with desmoid tumors.
- Ryzneuta Ryzneuta (efbemalenograstim alfa-vuxw) is a leukocyte growth factor to used to reduce the duration of febrile neutropenia in patients...
- Truqap Truqap (capivasertib) is an AKT inhibitor used in combination with fulvestrant for the treatment of advanced hormone receptor-positive...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...
- Libervant Libervant (diazepam) is a buccal film formulation of the approved benzodiazepine diazepam in development for the management of seizure clusters.